MedPath

Comparison of Lens Care Regimens With a Silicone Hydrogel Lens (Emerald)

Phase 3
Completed
Conditions
Myopia
Interventions
Drug: ClearCare
Drug: Optifree Replenish
Registration Number
NCT00520351
Lead Sponsor
University of Waterloo
Brief Summary

The purpose of the study is to evaluate and compare, on a daily wear basis, the performance of two contact lens care solutions when used with silicone hydrogel soft contact lenses with regards to comfort and dryness symptoms.

Detailed Description

The purpose of the study is to evaluate and compare, on a daily wear basis, the performance of two contact lens care solutions when used with silicone hydrogel soft contact lenses with regards to comfort and dryness symptoms by observing changes within the cornea and collecting subjective ratings

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  1. Is at least 17 years of age and has full legal capacity to volunteer.
  2. Has read, understood and signed an information consent letter.
  3. Is willing and able to follow instructions and maintain the appointment schedule.
  4. Is presently using either bi-weekly or monthly replacement lenses.
  5. Has symptoms of ocular dryness as determined by specific pre-screening criteria.
  6. Is correctable to a visual acuity of 6/9 or better (in each eye) with their habitual vision correction.
  7. Has clear corneas and no active ocular disease.
  8. Has had an ocular examination in the last two years.
Exclusion Criteria

A person will be excluded from the study if he/she:

  1. Is an asymptomatic lens wearer.
  2. Is a daily disposable contact lens wearer.
  3. Is a current extended wear contact lens wearer.
  4. Currently uses one of the study lens care regimens.
  5. Has any clinically significant blepharitis.
  6. Has undergone corneal refractive surgery.
  7. Is aphakic.
  8. Has any active ocular disease.
  9. Has any systemic disease affecting ocular health.
  10. Is using any systemic or topical medications that may affect ocular health.
  11. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  12. Is participating in any other type of clinical or research study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
1ClearCare-
2Optifree Replenish-
Primary Outcome Measures
NameTimeMethod
High Contrast Visual Acuity2 weeks

High Contrast Visual Acuity with contact lenses, was measured using standardized and computer generated logMAR chart.

10 Sloan letters adopted. VA chart's target size varied from logMAR 1.0 to -0.40 in 0.1 logMAR step.

Low Contrast Visual Acuity2 weeks

Low Contrast Visual Acuity with contact lenses, was measured using standardized and computer generated logMAR chart.

10 Sloan letters adopted. VA chart's target size varied from logMAR 1.0 to -0.40 in 0.1 logMAR step.

In-vivo Wettability2 weeks

Pre-lens non-invasive tear breakup time

Subjective Comfort Rating2 weeks

Numeric rating scale was administered. Comfort ratings (0 - 100), 0 = Very poor comfort and 100 = Excellent comfort.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre for Contact Lens Research, School of Optometry, University of Waterloo.

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath